Gene Panel Market – Powering Precision Diagnostics in Oncology and Beyond
The gene panel market sits at the core of precision diagnostics, enabling simultaneous analysis of multiple genes linked to specific diseases. It is a critical enabler of targeted therapy selection, risk assessment, and increasingly, population‑level screening strategies. The market was valued at approximately USD 6.8 billion in 2023, around USD 7.67 billion in 2024, and is projected to reach...
0 Σχόλια 0 Μοιράστηκε 3 Views 0 Προεπισκόπηση